David Nelles

David Nelles is a scientist, entrepreneur, and executive focused on building technologies in the field of RNA therapeutics and gene therapy.1 He completed his postdoctoral research in RNA-targeting gene therapy at the University of California, San Diego - School of Medicine from July 2016 to October 2017.1

Nelles has an extensive background in academia and industry:

Education

• PhD in Materials Engineering from the University of California, San Diego (2009-2014)1
• BS in Engineering Physics from the University of Pittsburgh (2005-2009)1

Professional Experience

• Currently serves as CEO and Co-founder of Tacit Therapeutics (April 2021-present)1
• Previously worked as CTO and Co-founder of Locanabio, Inc. (April 2016-January 2020)1
• Graduate Student Researcher in RNA-targeting CRISPR at the University of California, San Diego (September 2009-July 2016)1

Awards and Recognitions

• STAT Wunderkind 2017, recognizing him as part of the next generation of scientific superstars1
• BIOCOM Catalyst Award 2017, celebrating up-and-coming entrepreneurs in Southern California's life science industry1
• National Science Foundation Graduate Research Fellowship (2011-2014)1

Nelles' work focuses on innovative approaches to RNA editing and gene therapy, as evidenced by his current role at Tacit Therapeutics and his previous research experiences.12